Literature DB >> 19639176

Proteomics of rat prostate lobes treated with 2-N-hydroxylamino-1-methyl-6-phenylimidazo[4,5-b]pyridine, 5alpha-dihydrotestosterone, individually and in combination.

Telih Boyiri1, Richard I Somiari, Stephen Russell, Cesar Aliaga, Karam El-Bayoumy.   

Abstract

Epidemiological and preclinical studies suggest that environmental factors, hormonal responses and lifestyle, including diet and physical inactivity, are likely contributors to the initiation and progression of prostate cancer in humans. Although the effects of the food derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and/or testosterone (T) in the development of prostate cancer in the rat have been reported, the extent to which such compounds impact cancer related proteins is not clear. Knowledge of cancer-related proteins impacted by PhIP and/or T is prerequisite to developing novel strategies to early-detect prostate cancer. Male F344 rats were sacrificed, the prostate tissue isolated and separated into dorsolateral, ventral, and anterior lobes. The lobes were cultured and treated with 10(-3) M NHPhIP and/or 10(-7) M DT for 24 h. NHPhIP is the genotoxic form of PhIP and DT is the more proliferative form of T. We used 2D-DIGE and LC/MS/MS technologies to study the proteome of the prostate lobes to determine if the compounds will trigger detectable changes in expression of cancer-related proteins. Analysis of the signals from 2D-DIGE revealed that about 10% of proteins were differentially expressed in the NHPhIP and/or DT treatments compared to controls. Eight candidate protein spots detected by 2D-DIGE in at least two out of three lobes showed > or =2-fold difference between treated and control samples. Five out of the eight spots contained single proteins; including, phospholipase Calpha (PLP-Calpha), Rab7, SAR1a, ribosomal protein S7 (RPS7), and nucleoside diphosphate kinase (NDPK). A survey of the literature shows that NDPK expression is altered in human cancers, including prostate cancer. Thus, we validated the altered expression of NDPK by Western blot analysis. The concordance between 2D-DIGE and Western blot analysis was 80%. The results of this study demonstrate, for the first time, that the combination of 2D-DIGE and LC/MS/MS is a powerful tool for identification of proteins in the prostate tissue that are altered by environmental carcinogens and/or hormones.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639176      PMCID: PMC3679651          DOI: 10.3892/ijo_00000367

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  40 in total

1.  Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate.

Authors:  M C Bosland; M K Prinsen; T J Dirksen; B J Spit
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

2.  Differential protein expression in anatomical zones of the prostate.

Authors:  Helena Lexander; Bo Franzén; Daniel Hirschberg; Susanne Becker; Magnus Hellström; Tomas Bergman; Hans Jörnvall; Gert Auer; Lars Egevad
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

3.  Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate.

Authors:  T Shirai; L Cui; S Takahashi; M Futakuchi; M Asamoto; K Kato; N Ito
Journal:  Cancer Lett       Date:  1999-09-01       Impact factor: 8.679

4.  The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods.

Authors:  T Shirai; M Sano; S Tamano; S Takahashi; M Hirose; M Futakuchi; R Hasegawa; K Imaida; K Matsumoto; K Wakabayashi; T Sugimura; N Ito
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

5.  Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.

Authors:  David O Zamora; Michael Riviere; Dongseok Choi; Yuzhen Pan; Stephen R Planck; James T Rosenbaum; Larry L David; Justine R Smith
Journal:  Mol Vis       Date:  2007-10-30       Impact factor: 2.367

6.  Comparative epidemiology of cancer between the United States and Japan. A second look.

Authors:  E L Wynder; Y Fujita; R E Harris; T Hirayama; T Hiyama
Journal:  Cancer       Date:  1991-02-01       Impact factor: 6.860

7.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

Authors:  R K Ross; L Bernstein; R A Lobo; H Shimizu; F Z Stanczyk; M C Pike; B E Henderson
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

Review 8.  Hormones and prostate cancer: current perspectives and future directions.

Authors:  Ann W Hsing; Juergen K V Reichardt; Frank Z Stanczyk
Journal:  Prostate       Date:  2002-08-01       Impact factor: 4.104

Review 9.  The lessons of life: keynote address to the nutrition and cancer conference.

Authors:  R Doll
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

10.  Proteomic profiling of neuromas reveals alterations in protein composition and local protein synthesis in hyper-excitable nerves.

Authors:  Hong-Lei Huang; Cruz-Miguel Cendan; Carolina Roza; Kenji Okuse; Rainer Cramer; John F Timms; John N Wood
Journal:  Mol Pain       Date:  2008-08-12       Impact factor: 3.395

View more
  2 in total

1.  The effect of selenium enrichment on baker's yeast proteome.

Authors:  Karam El-Bayoumy; Arunangshu Das; Stephen Russell; Steven Wolfe; Rick Jordan; Kutralanathan Renganathan; Thomas P Loughran; Richard Somiari
Journal:  J Proteomics       Date:  2011-10-29       Impact factor: 4.044

2.  Senescence marker protein 30 (SMP30) expression in eukaryotic cells: existence of multiple species and membrane localization.

Authors:  Peethambaran Arun; Vineela Aleti; Kalpana Parikh; Veeraswamy Manne; Nageswararao Chilukuri
Journal:  PLoS One       Date:  2011-02-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.